Furthermore, researchers noted that the use of combination therapy, consisting of doxorubicin and Navitoclax (responsible for removing aging cells), led to only a 20% decrease in the running activity of p16-3MR mice, compared to the therapy with doxorubicin alone, where this coefficient reached 50% [60]
Evidence of oxidative stress in the circulation of ovarian cancer patients
doi:10.1002/14651858.CD009569.pub4
Peeters F, Cassiman C, Van Keer K, Levtchenko E, Veys K, Casteels I (2019) Ophthalmic outcome in a Belgian cohort of cystinosis patients treated with a compounded preparation of cysteamine eye drops: retrospective analysis
Simple API with established manufacturing, broad ANDA filer pool, automatic pharmacy substitution upon first generic approval